C-reactive protein as predictor for poor outcome after aneurysmal subarachnoid haemorrhage

Acta Neurochirurgica

Volumn 154, Issue 3, 2012, Pages 397-404

  Juvela, Seppo ^a,b,e   Kuhmonen, Johanna ^c   Siironen, Jari ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e NONE   (Finland)

Author keywords

C reactive protein; Cerebral aneurysm; Cerebral infarction; Outcome; Risk factor; Subarachnoid haemorrhage

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE;

EID: 84857897852     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-011-1243-7     Document Type: Article

References (29)

1. Al-Tamimi YZ, Orsi NM, Quinn AC, Homer-Vanniasinkam S, Ross SA (2010) A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg 73:654-667
2. Brotman DJ, Girod JP, Garcia MJ, Patel JV, Gupta M, Posch A, Saunders S, Lip GY,Worley S, Reddy S (2005) Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab 90:3202-3208 (Pubitemid 41014276)
3. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M (2009) C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. preventive services task force. Ann Intern Med 151:483-495
4. Dorhout Mees SMD, van Dijk GW, Algra A, Kempink DR, Rinkel GJ (2003) Glucose levels and outcome after subarachnoid hemorrhage. Neurology 61:1132-1133 (Pubitemid 37461953)
5. Drake CG (1988) Report of world federation of neurological surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 68:985-986
6. Elkind MS, Luna JM, Moon YP, Liu KM, Spitalnik SL, Paik MC, Sacco RL (2009) High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan study. Neurology 73:1300-1307
7. Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9 (Pubitemid 10159923)
8. Fountas KN, Tasiou A, Kapsalaki EZ, Paterakis KN, Grigorian AA, Lee GP, Robinson JS Jr (2009) Serum and cerebrospinal fluid Creactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article. Neurosurg Focus 26:E22
9. Haley EC Jr, Kassell NF, Torner JC (1993) A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. J Neurosurg 78:537-547 (Pubitemid 23099461)
10. Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP (1994) A randomized trial of two doses of nicardipine in aneurismal subarachnoid hemorrhage. A report of the cooperative aneurysm study. J Neurosurg 80:788-796 (Pubitemid 24129672)
11. Ilveskero S, Juvela S, Siironen J, Lassila R (2005) D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity. Neurosurgery 57:16-24
12. Inagawa T (2001) Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980-1989 and 1990-1998. Stroke 32:1499-1507
13. Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1:480-484
14. Juvela S (2002) Natural history of unruptured intracranial aneurysms: risks for aneurysm formation, growth, and rupture. Acta Neurochir Suppl 82:27-30
15. Juvela S (2003) Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke 34:1852-1858
16. Juvela S, Siironen J (2012) Early cerebral infarction as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. Eur J Neurol. doi:10.1111/j.1468-1331.2011.03523.x
17. Juvela S, Siironen J, Kuhmonen J (2005) Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg 102:998-1003 (Pubitemid 43193967)
18. Juvela S, Siironen J, Varis J, Poussa K, Porras M (2005) Risk factors for ischemic lesions following aneurysmal subarachnoid hemorrhage. J Neurosurg 102:194-201 (Pubitemid 43194066)
19. Kasius KM, Frijns CJM, Algra A, Rinkel GJE (2010) Association of platelet and leukocyte counts with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 29:576-583
20. Kubo Y, Ogasawara K, Kakino S, Kashimura H, Tomitsuka N, Sugawara A, Ogawa A (2008) Serum inflammatory adhesion molecules and high-sensitivity C-reactive protein correlates with delayed ischemic neurologic deficits after subarachnoid hemorrhage. Surg Neurol 69:592-596 (Pubitemid 351671852)
21. Lanzino G, Kassell NF, Germanson T, Truskowski L, Alves W (1993) Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 79:885-891 (Pubitemid 23342453)
22. Nieuwkamp DJ, Setz LE, Algra A, Linn FHH, de Rooij NK, Rinkel GJE (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635-642
23. Nordestgaard BG, Zacho J (2009) Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander? Nutr Metab Cardiovas 19:521-524
24. Numminen H, Kotila M, Waltimo O, Aho K, Kaste M (1996) Declining incidence and mortality rates of stroke in Finland from 1972 to 1991: results of three population-based stroke registers. Stroke 27:1487-1491 (Pubitemid 26295893)
25. Rothoerl RD, Axmann C, Pina AL, Woertgen C, Brawanski A (2006) Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 18:68-672
26. Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J, Lassila R (2003) No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg 99:953-959 (Pubitemid 44717388)
27. Siironen J, Porras M, Varis J, Poussa K, Hernesniemi J, Juvela S (2007) Early ischemic lesion on computed tomography: predictor of poor outcome among survivors of aneurysmal subarachnoid hemorrhage. J Neurosurg 107:1074-1079 (Pubitemid 350255167)
28. Vergouwen MDI, Vermeulen M, Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos EBWEM (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies-proposal of a multidisciplinary research group. Stroke 41:2391-2395
29. Vilkki JS, Juvela S, Siironen J, Ilvonen T, Varis J, Porras M (2004) Relationship of local infarctions to cognitive and psychosocial impairments after aneurysmal subarachnoid hemorrhage. Neurosurgery 55:790-803 (Pubitemid 39315027)